|
|
||||||||
J Neurophysiol (March 1, 2003). 10.1152/jn.00504.2002
Submitted on Submitted 2 July 2002; accepted in final form 10 November 2002
TRANSLATIONAL PHYSIOLOGY
1Department of Neurology, 2Division of Neuroscience, and 3Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030; 4Department of Cell Biology and Histology, University of Nijmegen, 6500 HB Nijmegen, The Netherlands; and 5The Houston VA Hospital Neurology Service
Schulz, Paul E.,
Adeka D. McIntosh,
Michael
R. Kasten,
Berend Wieringa, and
Henry F. Epstein.
A Role for Myotonic Dystrophy Protein Kinase in Synaptic
Plasticity. J. Neurophysiol. 89: 1177-1186, 2003. Myotonic dystrophy (DM) is associated with an
expanded triplet repeat in the 3'-untranslated region of the gene for
myotonic dystrophy protein kinase (DMPK), which may reduce DMPK
expression. It is unclear how reduced DMPK expression might contribute
to the symptoms of DM because the normal function of DMPK is not yet
understood. Thus we investigated the function of DMPK to gain insight
into how reduced DMPK expression might lead to cognitive dysfunction in
DM. We recently demonstrated a role for DMPK in modifying the
cytoskeleton, and remodeling of the cytoskeleton is thought to be
important for cognitive function. Therefore we hypothesized that DMPK
might normally contribute to synaptic plasticity and cognitive function
via an effect on actin cytoskeletal rearrangements. To test for
involvement of DMPK in synaptic plasticity, we utilized the DMPK null
mouse. This mouse showed no changes in baseline synaptic transmission
in hippocampal area CA1, nor any changes in long-term synaptic
potentiation (LTP) measured 3 h after induction. There was a
significant decrease, however, in the decremental potentiation with a
duration of 30-180 min that accompanies LTP. These results suggest a
role for DMPK in synaptic plasticity that could be relevant to the
cognitive dysfunction associated with DM.
This article has been cited by other articles:
![]() |
P. Garcia, Z. Ucurum, R. Bucher, D. I. Svergun, T. Huber, A. Lustig, P. V. Konarev, M. Marino, and O. Mayans Molecular insights into the self-assembly mechanism of dystrophia myotonica kinase FASEB J, June 1, 2006; 20(8): 1142 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, A. Mankodi, M. S. Swanson, R. T. Moxley, and C. A. Thornton Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons Hum. Mol. Genet., December 15, 2004; 13(24): 3079 - 3088. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lieberman, T. Takaki, B. Han, P. Santamaria, D. V. Serreze, and T. P. DiLorenzo Individual Nonobese Diabetic Mice Exhibit Unique Patterns of CD8+ T Cell Reactivity to Three Islet Antigens, Including the Newly Identified Widely Expressed Dystrophia Myotonica Kinase J. Immunol., December 1, 2004; 173(11): 6727 - 6734. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. O'Cochlain, C. Perez-Terzic, S. Reyes, G. C. Kane, A. Behfar, D. M. Hodgson, J. A. Strommen, X.-K. Liu, W. van den Broek, D. G. Wansink, et al. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy Hum. Mol. Genet., October 1, 2004; 13(20): 2505 - 2518. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |